Topics

CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System

09:00 EDT 11 Oct 2019 | Genetic Engineering News

Scientists led by a team at the Broad Institute of Massachusetts institute of Technology (MIT) and Harvard report on the development of a CRISPR-Cas13 enzyme-based technology called CARVER that can be programmed both to detect and to destroy ssRNA-based viruses in human cells. Initial tests in cultured cells showed that the system could reduce flu virus infectivity 300-fold within hours of viral exposure.

The post CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System

NEXT ARTICLE

More From BioPortfolio on "CRISPR-Cas13 Developed as Combination Antiviral and Diagnostic System"

Quick Search

Relevant Topic

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...